Pseudomyxoma peritonei screening: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Pseudomyxoma peritonei}} | {{Pseudomyxoma peritonei}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Nnasiri}} | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for pseudomyxoma peritonei. | ||
==References== | ==References== | ||
Latest revision as of 21:32, 14 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei screening On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei screening |
|
Risk calculators and risk factors for Pseudomyxoma peritonei screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for pseudomyxoma peritonei.
Screening
There is insufficient evidence to recommend routine screening for pseudomyxoma peritonei.